Technology Licensing
Topics
in This Section
The technologies listed below are available for licensing. Technologies are listed by type: Therapeutic Targets; Research Methods, Screens and Assays; Reagents; and Software.
Contact us by email, fax or by phone for licensing information.
Proton Beam Radiotherapy
- Particle Selection, Beam Monitoring and System Design for Laser-Accelerated Ion/Ion Beams for Radiotherapy (#03-12) - This invention provides significant advances in proton beam radiotherapy.
Building an Enormous Cancer Killer [PDF]
(Philadelphia Inquirer, 10-10-2006)
Therapeutics and Discovery Targets
Cancer
- Diagnostic Method for Early Pancreatic Cancer Detection
- Markers for Renal Cancer Diagnosis and Prognosis
- Novel Methods for Inhibiting Angiogenesis
- Markers for Early Diagnosis of Cancer
- MED1 - A Novel Gene Associated with Cancer Drug Resistance
- Human BUB Genes: Mitotic Checkpoint Kinases
- p53 repression elements in the Surviving and MAP4 promoters
- OVCA1 and OVCA2 Tumor Suppressor Genes
- Tumor-specific Antisense Therapy to Inhibit Bcl-2 Expression and Induce Apoptosis for Treatment of non-Hodgkin's Lymphoma
- Hef1/Cas-L, a Novel Signal Transduction Molecule Associated with Cell Motility, Growth, Apoptosis and Oncogenic Transformation [PDF]
-
Pregnancy-Associated Genetic Signatures in the Human Breast
Antibiotics, Industrial Chemicals and Herbicides
- Morphlock-1 - A Novel Specific Inhibitor of Tetrapyrrole Biosynthesis in Plants
- Porphobilinogen Synthase - A Novel Target for Antibiotic, Industrial Chemical and Herbicide Development
HIV/AIDS
- ATR Kinase - A Novel Target for Anti-Retroviral Drug Discovery
Cancer, HIV, Urology
Research Methods, Screens, and Assays
- ELISA Assay for the Detection of Ectromelia and Vaccinia Virus Antibodies in Mice, using Recombinant Viral Proteins
- The Two-Hybrid Dual Bait System: An Improved Two-Hybrid System for the Detection of Protein-Protein Interactions
- A Yeast Bioassay System for the Identification of Compounds that can Lower Plasma Homocysteine Levels
- p53-Dependent Asymmetric Cell Division: A Novel Screen for Growth Regulatory Compounds
- Methods of Screening for Inhibitors of Autoinhibited Proteins
- A Novel Tumor Cell Marker for use in Evaluating Cancer Therapeutics
- A Novel Cell Cycle-Specific Kinetochore Protein that Distinguishes G2 and M-Phase Cells
Animal Models
- Fox Chase MISIIR-TAg Mouse
- A New Model of Epithelial Ovarian Cancer
Vaccines
- Use of secreted/cell-bound poxvirus proteins (SPVP) and use thereof as vaccines and antiviral agents
Vectors, Antibodies, Reagents and Cell Lines
- Vectors
- PGLS20 vector: A novel dual purpose vector for protein expression in E.coli and S.cerevisiae [PDF]
- A Mutated Human Cytomegalovirus Expression Vector with Enhanced Ability to Express Foreign Genes
- A Chimeric Integrase-Containing Expression Vector for Promoting Targeted Integration of Foreign DNA into a Host Genome
- Expression vectors for MRP4 and MRP6 multidrug resistance genes
- PGLS20 vector: A novel dual purpose vector for protein expression in E.coli and S.cerevisiae [PDF]
- Polyclonal Antibodies: HEPL, ATM, FAP and PIX
- Monoclonal Antibodies: MAD1/2, HIRA, ASF1a, HEF, all Bub reagents, and CENP-E
- Endonucleases
- MED1 Glycosylase, a Tool for Detection of transition SNPs at CpG sites (CT-SNPs)
- Cell Lines
Medical Devices
Software
- ArrayExplorer® - Image-Processing Software for cDNA Microarray Analysis
PDF files require Adobe® Acrobat Reader to view.

Print this Page
E-mail This Page